5-Amino-1MQ Mechanism of Action
How a small-molecule enzyme inhibitor raises cellular SAM and NAD+ levels in fat tissue by blocking a single metabolic enzyme.
An Enzyme Inhibitor, Not a Peptide
5-Amino-1MQ is a small-molecule quinolinium compound, not a peptide, despite being sold in the same research category as compounds like Retatrutide and MOTS-c. Its mechanism is correspondingly different in kind: rather than activating a receptor or acting as a signaling molecule, it works by selectively and directly inhibiting a single enzyme.
Selectively Inhibiting NNMT
5-Amino-1MQ's target is nicotinamide N-methyltransferase (NNMT), an enzyme that methylates nicotinamide using S-adenosylmethionine (SAM) as the methyl donor. A 2014 genetic study established NNMT as a promising obesity research target: knocking down the NNMT gene in mice raised adipose SAM and NAD+ levels, increased energy expenditure, and protected against diet-induced obesity. 5-Amino-1MQ was developed four years later as a pharmacological tool to achieve the same inhibition using a small molecule rather than genetic knockdown.
Downstream Effects: Raising SAM and NAD+ in Adipose Tissue
By blocking NNMT's methylation activity, 5-Amino-1MQ research models show elevated intracellular SAM and NAD+ levels specifically within adipose (fat) tissue. Because NAD+ is central to mitochondrial energy metabolism (see our NAD+ mechanism of action page for more detail on that pathway), raising it in fat tissue is proposed to increase energy expenditure and fatty acid oxidation locally, which is the mechanistic basis for 5-Amino-1MQ's research use in diet-induced-obesity models.
How This Differs From MOTS-c and Retatrutide
5-Amino-1MQ's enzyme-inhibition mechanism is entirely distinct from the receptor-agonist mechanism of Retatrutide and the signaling-peptide mechanism of MOTS-c, despite all three being studied in KYIN's Weight Loss / Metabolic category. See our full 5-Amino-1MQ vs MOTS-c comparison for more detail.
- NNMT enzyme inhibition research
- Adipose tissue SAM and NAD+ level studies
- Energy expenditure and diet-induced-obesity model research
- Comparative mechanism research vs receptor- and peptide-based compounds
5-Amino-1MQ mechanism questions
Is 5-Amino-1MQ a peptide?
No. 5-Amino-1MQ is a small-molecule quinolinium compound that works by selectively inhibiting the enzyme NNMT, an entirely different mechanism category from the receptor-agonist and signaling-peptide compounds in KYIN's catalogue.
What happens when NNMT is inhibited?
Inhibiting NNMT raises intracellular SAM and NAD+ levels specifically in adipose tissue, which research models show increases energy expenditure and fatty acid oxidation, protecting against diet-induced obesity in mouse studies.
Interested in 5-Amino-1MQ?
See pricing and order on the product page, or browse our other weight-loss and metabolic research compounds.